BDBM620746 (8-syn)-3-{6-chloro-2-[(1- cyclopropyl-5-methyl-1H- pyrazol-4-yl)amino]quinazolin- 7-yl}-8-methyl-3-azabicyclo[3.2.1] octan-8-ol::US20230303540, Example Ex-3.27

SMILES Cc1c(Nc2ncc3cc(Cl)c(cc3n2)N2C[C@@H]3CC[C@H](C2)[C@]3(C)O)cnn1C1CC1

InChI Key InChIKey=UWRMUBXLSJDNCM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 620746   

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM620746((8-syn)-3-{6-chloro-2-[(1- cyclopropyl-5-methyl-1H...)
Affinity DataIC50: 0.486nMAssay Description:The LRRK2 kinase activity reported herein as IC50 values was determined with LanthaScreen technology from Life Technologies Corporation (Carlsbad, CA...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent